Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FORG
3101
PUT
DELISTED
ForgeRock, Inc.
FORG
| $2.88M | ﹤0.01% |
140,300
+89,300
| +175% | +$1.79M |
|
3102
Skyworks Solutions
SWKS
$9.9B
| $2.88M | ﹤0.01% |
26,007
-930,144
| -97% | -$98.1M |
|
3103
Southwest Gas
SWX
$6.45B
| $2.88M | ﹤0.01% |
45,181
+39,481
| +693% | +$2.33M |
|
3104
CALL
Teva Pharmaceuticals
TEVA
$42.5B
| $2.87M | ﹤0.01% |
381,800
+1,000
| +0.3% | +$8.11K |
|
|
VRTV
3105
DELISTED
VERITIV CORPORATION
VRTV
| $2.87M | ﹤0.01% |
22,881
-44,377
| -66% | -$5.19M |
|
3106
Richardson Electronics
RELL
$263M
| $2.87M | ﹤0.01% |
174,130
-276,956
| -61% | -$4.79M |
|
3107
Skyward Specialty Insurance
SKWD
$2.36B
| $2.87M | ﹤0.01% |
112,974
+20,218
| +22% | +$467K |
|
3108
CALL
Estee Lauder
EL
$37.4B
| $2.87M | ﹤0.01% |
14,600
-13,100
| -47% | -$2.78M |
|
3109
CALL
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $2.86M | ﹤0.01% |
+33,100
| New | +$2.83M |
|
3110
AZZ Inc
AZZ
$4.16B
| $2.86M | ﹤0.01% |
65,847
+23,676
| +56% | +$909K |
|
3111
Progress Software
PRGS
$1.84B
| $2.86M | ﹤0.01% |
49,242
+38,906
| +376% | +$2.21M |
|
3112
CALL
Campbell Soup
CPB
$6.98B
| $2.86M | ﹤0.01% |
62,500
+51,500
| +468% | +$2.66M |
|
3113
Haemonetics
HAE
$4.73B
| $2.86M | ﹤0.01% |
33,552
+20,670
| +160% | +$1.75M |
|
3114
TD Synnex
SNX
$20.3B
| $2.85M | ﹤0.01% |
30,351
-513,153
| -94% | -$47M |
|
3115
CS Disco
LAW
$282M
| $2.85M | ﹤0.01% |
347,058
-10,805
| -3% | -$74.1K |
|
3116
ArcelorMittal
MT
$56.1B
| $2.85M | ﹤0.01% |
104,246
-57,998
| -36% | -$1.59M |
|
3117
Evertec
EVTC
$1.79B
| $2.84M | ﹤0.01% |
77,143
-137,384
| -64% | -$4.76M |
|
3118
CALL
Green Plains
GPRE
$1.03B
| $2.84M | ﹤0.01% |
+88,000
| New | +$2.79M |
|
3119
CALL
Flywire
FLYW
$2.29B
| $2.84M | ﹤0.01% |
+91,400
| New | +$2.74M |
|
3120
CALL
CRISPR Therapeutics
CRSP
$5.58B
| $2.84M | ﹤0.01% |
50,500
+20,500
| +68% | +$1.16M |
|
|
SKX
3121
PUT
DELISTED
Skechers
SKX
| $2.83M | ﹤0.01% |
+53,800
| New | +$2.75M |
|
3122
CALL
Camden Property Trust
CPT
$12.3B
| $2.83M | ﹤0.01% |
26,000
+5,000
| +24% | +$539K |
|
|
3123
PUT
Green Plains
GPRE
$1.03B
| $2.82M | ﹤0.01% |
+87,600
| New | +$2.77M |
|
3124
Neuropace
NPCE
$495M
| $2.82M | ﹤0.01% |
628,933
-102,677
| -14% | -$465K |
|
3125
ProShares UltraPro S&P 500
UPRO
$5.57B
| $2.82M | ﹤0.01% |
59,539
-5,412
| -8% | -$221K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.